Compare BSVN & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BSVN | CGC |
|---|---|---|
| Founded | 2004 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Banks | Pharmaceuticals and Biotechnology |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 416.1M | 401.0M |
| IPO Year | 2018 | 2023 |
| Metric | BSVN | CGC |
|---|---|---|
| Price | $49.36 | $0.89 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 1 |
| Target Price | ★ $53.67 | N/A |
| AVG Volume (30 Days) | 27.8K | ★ 3.3M |
| Earning Date | 04-14-2026 | 05-29-2026 |
| Dividend Yield | ★ 2.48% | N/A |
| EPS Growth | N/A | ★ 84.17 |
| EPS | ★ 1.25 | N/A |
| Revenue | N/A | ★ $12,759,000.00 |
| Revenue This Year | $5.05 | $8.27 |
| Revenue Next Year | $4.05 | $15.68 |
| P/E Ratio | $39.55 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $38.50 | $0.84 |
| 52 Week High | $53.00 | $2.38 |
| Indicator | BSVN | CGC |
|---|---|---|
| Relative Strength Index (RSI) | 51.67 | 40.09 |
| Support Level | $40.17 | $0.84 |
| Resistance Level | $53.00 | $1.23 |
| Average True Range (ATR) | 1.52 | 0.03 |
| MACD | -0.36 | -0.00 |
| Stochastic Oscillator | 34.21 | 33.47 |
Bank7 Corp is a full-service commercial bank focused on providing customers with exceptional service and meeting their banking needs through a variety of commercial and retail financial services. It offers deposit banking products, including commercial deposit services, commercial checking, money market, and other deposit accounts, and retail deposit services such as certificates of deposit, money market accounts, checking accounts, negotiable order of withdrawal accounts, savings accounts, and automated teller machine access. etc. It generates revenues from interest income from financial instruments and non-interest income and service charges on deposit accounts.
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.